Finance

Beta
Lists
CAMP:NASDAQ
CAMP4 Therapeutics Corp
$4.44
+5.71%
(+0.24) 1D
$4.44
0.00% (0.00)
After hours
Closed: Jun 29, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CAMP...
Open
$4.20
High
$4.50
Low
$4.07
Mkt. cap
230.55M
Avg. vol.
227.27K
Volume
154.60K
52-wk high
$7.75
52-wk low
$1.32
EPS
-$2.24
Shares outstanding
51.93M
No. of employees
48
Open
$4.20
High
$4.50
Low
$4.07
Mkt. cap
230.55M
Avg. vol.
227.27K
Volume
154.60K
52-wk high
$7.75
52-wk low
$1.32
EPS
-$2.24
Shares outstanding
51.93M
No. of employees
48
News stories
From sources across the web
About CAMP4 Therapeutics Corp
CEO-
Employees48
Founded2015
Headquarters-
SectorBiotechnology
Websitecamp4tx.com
Analyst ratings
Based on 8 analysts giving stock ratings to CAMP in the past 3 months
Strong buy
Buy
8
Hold
0
Sell
0
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for CAMP in the last 3 months.
Highest
Current $4.44
$12.00 (+170.27%)
Average
$8.36 (+88.29%)
Lowest
$6.50 (+46.40%)
Analyst
Recommendation
Action
Price target
Projected
Date
Myles Minter
William Blair
Buy
Reiterated
-
-
06/25/2026
Anupam Rama
J.P. Morgan
Buy
Upgraded
$9.00
+102.7%
06/22/2026
Keay Nakae
Chardan Capital
Buy
Initiated
$6.50
+46.4%
06/10/2026
Edward Tenthoff
Piper Sandler
Buy
Reiterated
$12.00
+170.3%
05/15/2026
Yun Zhong
Wedbush
Buy
Maintained
$8.00
+80.2%
05/08/2026
Steven Seedhouse
Cantor Fitzgerald
Buy
Maintained
$7.00
+57.7%
05/08/2026
Seema Sheoran
Rodman & Renshaw
Buy
Initiated
$7.00
+57.7%
04/14/2026
Mani Foroohar
Leerink Partners
Buy
Maintained
$9.00
+102.7%
04/02/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.50M
795.00K
348.00K
1.29M
Cost of goods sold
10.34M
9.36M
8.36M
10.16M
Cost of revenue
10.34M
9.36M
8.36M
10.16M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.18M
4.60M
4.77M
4.20M
Operating expense
4.18M
4.60M
4.77M
4.20M
Total operating expenses
14.52M
13.95M
13.12M
14.36M
Operating income
-13.03M
-13.16M
-12.78M
-13.07M
Other non operating income
-11.00K
-1.87M
-28.22M
-6.17M
EBT including unusual items
-12.59M
-15.10M
-40.28M
-18.33M
EBT excluding unusual items
-12.59M
-14.60M
-40.28M
-18.33M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-12.59M
-15.10M
-40.28M
-18.33M
Net profit margin
-840.81%
-1,899.25%
-11,575.86%
-1,416.62%
Earnings per share
-0.62
-0.54
-0.23
-0.21
Interest and investment income
453.00K
423.00K
716.00K
910.00K
Interest expense
-1.00K
-2.00K
-
-
Net interest expenses
452.00K
421.00K
716.00K
910.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-12.60M
-12.74M
-12.40M
-12.55M
Gain or loss from assets sale
-
67.00K
191.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer